<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02563990</url>
  </required_header>
  <id_info>
    <org_study_id>20150583</org_study_id>
    <nct_id>NCT02563990</nct_id>
  </id_info>
  <brief_title>Injection Pressure &amp; Adductor Canal Block</brief_title>
  <official_title>The Impact of Injection Pressure During Adductor Canal Nerve Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, single-blinded human clinical trial that will examine how
      injection pressure influences the spread of a given volume of injectate in the adductor
      canal, during adductor canal nerve block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, single-blinded human clinical trial that will examine how
      injection pressure influences the spread of a given volume of injectate in the adductor
      canal, during adductor canal nerve block. The study population will be patients undergoing
      elective anterior cruciate ligament repair in the distal lower extremity and receiving
      preoperative adductor canal nerve blocks for postoperative analgesia. They will be randomized
      into two groups of 25 patients each. The investigators speculate that high injection
      pressures (&gt;20 psi) will lead to greater spread of local anesthetic than low injection
      pressures (&lt;15 psi) during mid-thigh adductor canal nerve blocks. The primary endpoint is the
      spread of injectate, defined as the distance between the uppermost and lowermost limits of
      spread of local anesthetic as assessed by ultrasound. The secondary endpoints are the
      incidence of femoral and sciatic nerve blocks 30 minutes after block placement, amount of IV
      opioid administered intraoperatively and postoperatively, preoperative and postoperative pain
      (Numeric Rating Scale, 0-10), and postoperative physical therapy milestone achievement.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to recruit additional patients due to transfer of surgical service (ortho sports
    medicine) and recruitable cases to another institution.
  </why_stopped>
  <start_date type="Actual">December 3, 2015</start_date>
  <completion_date type="Actual">December 9, 2016</completion_date>
  <primary_completion_date type="Actual">November 9, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spread of Injectate</measure>
    <time_frame>Immediate post-procedure on day 1</time_frame>
    <description>Our primary endpoint is the spread of injectate, defined as the distance between the uppermost and lowermost limits of spread of local anesthetic as assessed by ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Events of Femoral Nerve Block 30 Minutes After Block Placement</measure>
    <time_frame>post-procedure and postoperative on day 1</time_frame>
    <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the femoral nerve distribution, then an outcome of a femoral nerve block will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Events of Sciatic Nerve Block 30 Minutes After Block Placement</measure>
    <time_frame>post-procedure and postoperative on day 1</time_frame>
    <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the sciatic nerve distribution, then an outcome of a sciatic nerve block will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain Scores (Numeric Rating Scale, 0-10)</measure>
    <time_frame>postoperative on day 1</time_frame>
    <description>Patients will rate their pain after surgery on a scale from 0-10, with 0 being no pain, and 10 being the worst pain of their life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Physical Therapy Milestone Achievement</measure>
    <time_frame>postoperative week 1</time_frame>
    <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Physical Therapy Milestone Achievement</measure>
    <time_frame>postoperative week 2</time_frame>
    <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Physical Therapy Milestone Achievement</measure>
    <time_frame>postoperative week 3</time_frame>
    <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Physical Therapy Milestone Achievement</measure>
    <time_frame>postoperative week 4</time_frame>
    <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Administration</measure>
    <time_frame>day 1</time_frame>
    <description>Intraoperative and immediate postoperative opioid administration. Calculated as morphine milliequivalent (in milligrams).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Orthopedic Disorders</condition>
  <condition>Injury of Anterior Cruciate Ligament</condition>
  <arm_group>
    <arm_group_label>High Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High Pressure Injection</intervention_name>
    <description>Adductor canal block performed at greater than 20 psi injection pressure</description>
    <arm_group_label>High Pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low Pressure Injection</intervention_name>
    <description>Adductor canal block performed at less than 15 psi injection pressure</description>
    <arm_group_label>Low Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Planned general anesthetic.

          2. American Society of Anesthesia classes I, II, or III.

          3. Patients aged 18-65.

          4. English-speaking patients.

        Exclusion criteria:

          1. ASA classes IV and V.

          2. Patients younger than 18 or older than 65.

          3. Contraindication to regional anesthesia (coagulopathy, patient refusal).

          4. Allergy to local anesthetic or other study medications.

          5. BMI &gt; 35 kg/m2.

          6. Chronic opioid use (daily or almost daily use for &gt; 3 months).

          7. Active illicit drug use.

          8. Additional surgical site other than the limb for adductor canal block.

          9. Pregnancy.

         10. Preexisting neuropathy in the operative limb.

         11. Inability to communicate to investigators or hospital staff.

         12. Inability to speak or understand English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Missair, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 25, 2015</study_first_submitted>
  <study_first_submitted_qc>September 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2015</study_first_posted>
  <results_first_submitted>December 11, 2019</results_first_submitted>
  <results_first_submitted_qc>January 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 13, 2020</results_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Andres Missair</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 10, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT02563990/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>High Pressure</title>
          <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
        </group>
        <group group_id="P2">
          <title>Low Pressure</title>
          <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Pressure</title>
          <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
        </group>
        <group group_id="B2">
          <title>Low Pressure</title>
          <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="14"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="14"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Spread of Injectate</title>
        <description>Our primary endpoint is the spread of injectate, defined as the distance between the uppermost and lowermost limits of spread of local anesthetic as assessed by ultrasound.</description>
        <time_frame>Immediate post-procedure on day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Spread of Injectate</title>
          <description>Our primary endpoint is the spread of injectate, defined as the distance between the uppermost and lowermost limits of spread of local anesthetic as assessed by ultrasound.</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" lower_limit="8.5" upper_limit="29"/>
                    <measurement group_id="O2" value="10" lower_limit="2" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Events of Femoral Nerve Block 30 Minutes After Block Placement</title>
        <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the femoral nerve distribution, then an outcome of a femoral nerve block will be recorded.</description>
        <time_frame>post-procedure and postoperative on day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Events of Femoral Nerve Block 30 Minutes After Block Placement</title>
          <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the femoral nerve distribution, then an outcome of a femoral nerve block will be recorded.</description>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Events of Sciatic Nerve Block 30 Minutes After Block Placement</title>
        <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the sciatic nerve distribution, then an outcome of a sciatic nerve block will be recorded.</description>
        <time_frame>post-procedure and postoperative on day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Events of Sciatic Nerve Block 30 Minutes After Block Placement</title>
          <description>Sensory testing will use a pinprick method in the femoral (anterior thigh), saphenous (medial calf proximal to the medial malleolus, top of the patella) and sciatic (posterolateral calf, plantar surface of the foot) nerve distributions; if patients are unable to feel the stimulus in the sciatic nerve distribution, then an outcome of a sciatic nerve block will be recorded.</description>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain Scores (Numeric Rating Scale, 0-10)</title>
        <description>Patients will rate their pain after surgery on a scale from 0-10, with 0 being no pain, and 10 being the worst pain of their life.</description>
        <time_frame>postoperative on day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain Scores (Numeric Rating Scale, 0-10)</title>
          <description>Patients will rate their pain after surgery on a scale from 0-10, with 0 being no pain, and 10 being the worst pain of their life.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="O2" value="4" lower_limit="3.25" upper_limit="5.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Physical Therapy Milestone Achievement</title>
        <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
        <time_frame>postoperative week 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Physical Therapy Milestone Achievement</title>
          <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="18" upper_limit="68"/>
                    <measurement group_id="O2" value="30" lower_limit="8" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Physical Therapy Milestone Achievement</title>
        <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
        <time_frame>postoperative week 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Physical Therapy Milestone Achievement</title>
          <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="32" upper_limit="75"/>
                    <measurement group_id="O2" value="50" lower_limit="22" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Physical Therapy Milestone Achievement</title>
        <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
        <time_frame>postoperative week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Physical Therapy Milestone Achievement</title>
          <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="30" upper_limit="72"/>
                    <measurement group_id="O2" value="51" lower_limit="40" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Physical Therapy Milestone Achievement</title>
        <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
        <time_frame>postoperative week 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Physical Therapy Milestone Achievement</title>
          <description>The patient will be evaluated by physical therapy postoperatively using the Lower Extremity Function Scale (LEFS). The LEFS is a self-reporting measure (0-80 score range, where 0 is complete disability and 80 is fully functional).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="59" upper_limit="78"/>
                    <measurement group_id="O2" value="65" lower_limit="20" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Administration</title>
        <description>Intraoperative and immediate postoperative opioid administration. Calculated as morphine milliequivalent (in milligrams).</description>
        <time_frame>day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Pressure</title>
            <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure</description>
          </group>
          <group group_id="O2">
            <title>Low Pressure</title>
            <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Administration</title>
          <description>Intraoperative and immediate postoperative opioid administration. Calculated as morphine milliequivalent (in milligrams).</description>
          <units>milligrams</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.909" spread="2.827"/>
                    <measurement group_id="O2" value="16.033" spread="2.438"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <desc>Adverse events collected as related to intervention only, as assessed by treating physician.</desc>
      <group_list>
        <group group_id="E1">
          <title>High Pressure</title>
          <description>High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
High Pressure Injection: Adductor canal block performed at greater than 20 psi injection pressure
High Pressure Injection: Ropivacaine 0.2% injection at greater than 20 psi injection pressure</description>
        </group>
        <group group_id="E2">
          <title>Low Pressure</title>
          <description>Low pressure injection of Ropivacaine local anesthetic at less than 15 psi
Low Pressure Injection: Adductor canal block performed at less than 15 psi injection pressure
Low Pressure Injection: Ropivacaine 0.2% injection at less than 15 psi injection pressure</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Trial was terminated early due to inability to recruit additional subjects after the participating surgeons were staffed at a different hospital and no replacement surgical service was established.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Andres Missair</name_or_title>
      <organization>University of Miami</organization>
      <phone>3055857037</phone>
      <email>amissair@miami.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

